00:00
1928
Chris Paddon of Amyris Biotechnologies discusses "Microbially-Derived Artemisinin: Engineering Yeast Using Synthetic Biology to Stabilize the Supply of an Important Anti-malarial Drug for the Developing World" at the Yeast Synthetic Biology Workshop on October 16, 2010 in San Francisco and hosted by Life Technologies and the Synthetic Biology Engineering Research Center (SynBERC).